Prevention of Dementia by ACE Inhibitors and Angiotensin Receptor Blockers - Potential but Not Proven

International Journal of Clinical Practice - United States
doi 10.1111/j.1742-1241.2010.02490.x
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Wiley

Related search

ACE-inhibitors but Not Endothelin Receptor Blockers Prevent Podocyte Loss in Early Diabetic Nephropathy

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2003English

Angiotensin-Converting Enzyme Inhibitors (ACE-Is) Versus Angiotensin- Receptor Blockers (ARBs): Any Superiority?

Journal of Hypertension- Open Access
2012English

Dual Blockade of the Renin-Angiotensin System With Angiotensin Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs)

British Journal of Clinical Pharmacology
Pharmacology
2011English

Interaction of Spironolactone With ACE Inhibitors or Angiotensin Receptor Blockers: Analysis of 44 Cases

BMJ
2003English

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Does the Use of ACE Inhibitors or Angiotensin Receptor Blockers Affect Bone Loss in Older Men?

Osteoporosis International
MedicineEndocrinologyMetabolismDiabetes
2011English

Should ACE Inhibitors and Angiotensin Receptor Blockers Be Withdrawn in the Current Setting of COVID-19 Infection?

Wits Journal of Clinical Medicine
2020English

Comparison of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors for Glycaemic Regulation

Endocrine Abstracts
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy